A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriage
Authors:
- Baris AtaBABaris Ata
- Seang Lin TanSTSeang Lin Tan
- Fady ShehataFSFady Shehata
- Hananel HolzerHHHananel Holzer
- William BuckettWBWilliam Buckett
- 1 March 2011
- journal article
- review article
- Published by Elsevier in Fertility and Sterility
- Vol. 95 (3) , 1080-1085.e2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trialHuman Reproduction, 2010
- Intravenous immunoglobulin (IVIG) for treatment of idiopathic secondary recurrent miscarriage (ISRM): a prospective, randomized, double-blinded, placebo-controlled, multi-centered trialFertility and Sterility, 2009
- Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic reviewBJOG: An International Journal of Obstetrics & Gynaecology, 2007
- Recurrent miscarriageThe Lancet, 2006
- Immunotherapy for recurrent miscarriage2006
- Immunologic tests and IVF: “Please, enough already”Fertility and Sterility, 2000
- Intravenous Immunoglobulin for Treatment of Recurrent Pregnancy LossAmerican Journal of Reproductive Immunology, 1995
- Intravenous immunoglobulin in the prevention of recurrent miscarriageBJOG: An International Journal of Obstetrics & Gynaecology, 1995
- Intravenous immunoglobulin in the prevention of recurrent miscarriageBJOG: An International Journal of Obstetrics & Gynaecology, 1994
- Incidence of Early Loss of PregnancyNew England Journal of Medicine, 1988